Showing results (161-170 of 631) with videos related to
Sort By:
Pageof 64
Blood|January 1, 1988
Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbitsD Collen, J M Stassen, G LarsenEuropean Journal of Biochemistry|November 1, 1991
Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cellsE A Thompson, L Nelles, D CollenThe Journal of Biological Chemistry|September 25, 1986
Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasmaD C Stump, M Thienpont, D CollenEuropean Journal of Biochemistry|July 1, 1986
Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodiesP Holvoet, H R Lijnen, D CollenVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1995
Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosisD Collen, H R Lijnen, S VanderschuerenThe Journal of Biological Chemistry|May 10, 1984
Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin IIIM Hoylaerts, W G Owen, D CollenThe Journal of Clinical Investigation|March 1, 1985
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulationM Colucci, J A Paramo, D CollenThe Journal of Biological Chemistry|January 25, 1986
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complexD C Stump, M Thienpont, D CollenThrombosis and Haemostasis|November 1, 1995
Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated miceP J Declerck, M Verstreken, D CollenThe Journal of Biological Chemistry|February 25, 1984
Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activatorC Zamarron, H R Lijnen, D CollenPageof 64